Want to see TXG full AI Analyst Report?
Instruments Revenue by Type
Shows revenue generated from different types of instruments, highlighting which products are driving sales and indicating the company's focus areas in technology and innovation.10x Genomics is experiencing a significant decline in instrument revenue, with Chromium instruments seeing a sharp drop, exacerbated by a challenging academic funding environment and CapEx constraints. Despite these hurdles, the company is strategically enhancing its capabilities through acquisitions and new product launches, aiming to bolster its position in single-cell analysis. The earnings call underscores robust demand for single-cell solutions, but the ongoing funding challenges and declining instrument sales present substantial risks to near-term revenue stability.
Date | Chromium Instruments | Spatial Instruments |
|---|---|---|
Jun 30, 2026 | $3.09M | $4.57M |
Mar 31, 2026 | $5.22M | $6.04M |
Dec 31, 2025 | $6.11M | $9.36M |
Sep 30, 2025 | $4.93M | $7.07M |
Jun 30, 2025 | $5.73M | $8.77M |
Mar 31, 2025 | $5.91M | $8.90M |
Dec 31, 2024 | $10.93M | $13.43M |
Sep 30, 2024 | $7.64M | $11.41M |
Jun 30, 2024 | $8.79M | $15.06M |
Mar 31, 2024 | $7.85M | $17.60M |